Sign in

CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company

Ernexa Therapeutics Inc.

Sign in to watch
Ticker
ERNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
311103425
Phone
(617) 798-6700
Business address
1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
Former names
Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC

Securities

  • ERNA Common Stock Nasdaq
  • ERNAW Warrants Nasdaq
  1. CORRESP Other Correspondence Between Filers and SEC Staff
  2. 8-K Event Results of operations
  3. CORRESP Other Correspondence Between Filers and SEC Staff
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. CORRESP Other Correspondence Between Filers and SEC Staff
  6. 8-K Event Other events
  7. 8-K Event Executive or director change
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. 4 Insider Changes in Ownership
  10. 3 Insider Initial Statement of Ownership
  11. UPLOAD Other SEC-generated Letter
  12. SC 13D/A Stake Beneficial Ownership Report
  13. CORRESP Other Correspondence Between Filers and SEC Staff
  14. UPLOAD Other SEC-generated Letter
  15. 8-K Event Executive or director change · Bylaws or fiscal year change
  16. 4 Insider Changes in Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 8-K Event Executive or director change
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 60 of 77 · 1,525 filings